Imatinib Completed Phase 2 Trials for Accelerated Phase Chronic Myelogenous Leukemia / Blastic Phase Chronic Myelogenous Leukemia / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Childhood Chronic Myelogenous Leukemia / Relapsing Chronic Myelogenous Leukemia Treatment